BASF stock hits Evonik hurdle after weekend takeover talks
Published on 11/10/2026 at 10:31 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWSEvonik Maintains Its Resistance
- Evonik continues to reject BASF's increased takeover proposal after executives met at the weekend.
- No further meetings are currently scheduled, leaving BASF without a roadmap for formal negotiations.
Evonik continues to reject BASF's increased takeover offer after senior executives from both companies held preliminary talks over the weekend, Reuters reported on Monday, November 9. The report cited people familiar with the matter, while both companies declined to comment on the meeting.
BASF's proposal values Evonik at 11.18 billion euros, or 24 euros per share. Evonik rejected BASF's initial 22.15-euro-per-share offer in September and turned down the improved approach at the end of October, saying the proposal was not sufficient to begin formal negotiations.
No Roadmap For Formal Negotiations
Reuters reported that no further meetings are currently scheduled. The outcome leaves BASF facing resistance to a transaction that would expand its specialty-chemicals portfolio but also require agreement with a target pursuing its own restructuring and independent strategy.
BASF Chief Executive Markus Kamieth has described a combination as a possible response to global competition, while the company has also said it would not overpay. For investors, the immediate issue is whether BASF can persuade Evonik to move beyond preliminary discussions without weakening its capital discipline.
At 18:48 CET on Monday, November 9, BASF stock traded at 53.93 euros on Lang & Schwarz, 0.15 percent above the Xetra close of Monday, November 9 at 53.85 euros. The quote predates Tuesday's Xetra session and therefore reflects the latest available evening indication rather than a new intraday move.
BASF stock at a glance
- Company: BASF SE
- ISIN: DE000BASF111
- Trading symbol: BAS.DE
- Lang & Schwarz quote: 53.93 euros at 18:48 CET on November 9, 2026
- Xetra close: 53.85 euros on November 9, 2026
- 52-week range: 41.62 to 56.56 euros
- Market capitalization: 46.65 billion euros at 09:12 UTC on November 10, 2026
European chemical shares remain sensitive to takeover expectations, industrial demand and capital-allocation decisions. Investors can follow the broader DAX market environment as negotiations around Evonik develop.
Further reporting will depend on whether the two companies resume discussions or whether Evonik continues with its standalone plan. More news and analyses on BASF stock.
